Articles liés à Role of PDE4 Inhibitor Through Theobromine Topical...
Résultats de recherche pour Role of PDE4 Inhibitor Through Theobromine Topical...
Image d'archives
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9786209906527
Acheter neuf
EUR 80,44
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis (Paperback)
Edité par
LAP Lambert Academic Publishing, 2026
ISBN 10 : 6209906524
ISBN 13 : 9786209906527
Neuf
Paperback
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. "Psoriasis" is a chronic, non-infectious autoimmune inflammatory disease affecting the skin, joints, and other systemic organs. It is primarily characterized by hyperproliferation and abnormal differentiation of keratinocytes, along with infiltration of immune cells into the dermal layer, resulting in red, scaly, and disfigured patches on the skin. The disease pathogenesis involves complex interactions among dendritic cells, T cells, and keratinocytes that activate TNF-a, IL-23/IL-17, and JAK/STAT pathways. Current therapies, such as topical corticosteroids, phototherapy, and biologics targeting specific cytokines, manifest considerable challenges, including adverse effects, treatment resistance, inconvenient administration, and prohibitive costs. Phosphodiesterase-4 (PDE4) inhibition represents a promising therapeutic strategy by preventing cAMP degradation and modulating inflammatory responses. Topical administration of a drug like Theobromine offers a significant advantage for psoriasis treatment, allowing targeted application to affected areas while minimizing systemic exposure and associated side effects. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9786209906527
Acheter neuf
EUR 81,49
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis
Edité par
LAP Lambert Academic Publishing, 2026
ISBN 10 : 6209906524
ISBN 13 : 9786209906527
Neuf
Couverture souple
Vendeur : California Books, Miami, FL, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. N° de réf. du vendeur I-9786209906527
Acheter neuf
EUR 81,50
Livraison gratuite
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9786209906527
Acheter neuf
EUR 77,73
Expédition à EUR 3,82
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis
Edité par
Omniscriptum, LAP Lambert Academic Publishing, 2026
ISBN 10 : 6209906524
ISBN 13 : 9786209906527
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -'Psoriasis' is a chronic, non-infectious autoimmune inflammatory disease affecting the skin, joints, and other systemic organs. It is primarily characterized by hyperproliferation and abnormal differentiation of keratinocytes, along with infiltration of immune cells into the dermal layer, resulting in red, scaly, and disfigured patches on the skin. The disease pathogenesis involves complex interactions among dendritic cells, T cells, and keratinocytes that activate TNF- , IL-23/IL-17, and JAK/STAT pathways. Current therapies, such as topical corticosteroids, phototherapy, and biologics targeting specific cytokines, manifest considerable challenges, including adverse effects, treatment resistance, inconvenient administration, and prohibitive costs. Phosphodiesterase-4 (PDE4) inhibition represents a promising therapeutic strategy by preventing cAMP degradation and modulating inflammatory responses. Topical administration of a drug like Theobromine offers a significant advantage for psoriasis treatment, allowing targeted application to affected areas while minimizing systemic exposure and associated side effects. 100 pp. Englisch. N° de réf. du vendeur 9786209906527
Acheter neuf
EUR 66,90
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis
Edité par
KS Omniscriptum Publishing, 2026
ISBN 10 : 6209906524
ISBN 13 : 9786209906527
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - 'Psoriasis' is a chronic, non-infectious autoimmune inflammatory disease affecting the skin, joints, and other systemic organs. It is primarily characterized by hyperproliferation and abnormal differentiation of keratinocytes, along with infiltration of immune cells into the dermal layer, resulting in red, scaly, and disfigured patches on the skin. The disease pathogenesis involves complex interactions among dendritic cells, T cells, and keratinocytes that activate TNF- , IL-23/IL-17, and JAK/STAT pathways. Current therapies, such as topical corticosteroids, phototherapy, and biologics targeting specific cytokines, manifest considerable challenges, including adverse effects, treatment resistance, inconvenient administration, and prohibitive costs. Phosphodiesterase-4 (PDE4) inhibition represents a promising therapeutic strategy by preventing cAMP degradation and modulating inflammatory responses. Topical administration of a drug like Theobromine offers a significant advantage for psoriasis treatment, allowing targeted application to affected areas while minimizing systemic exposure and associated side effects. N° de réf. du vendeur 9786209906527
Acheter neuf
EUR 69,70
Expédition à EUR 35
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis (Paperback)
Edité par
LAP Lambert Academic Publishing, 2026
ISBN 10 : 6209906524
ISBN 13 : 9786209906527
Neuf
Paperback
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : new. Paperback. "Psoriasis" is a chronic, non-infectious autoimmune inflammatory disease affecting the skin, joints, and other systemic organs. It is primarily characterized by hyperproliferation and abnormal differentiation of keratinocytes, along with infiltration of immune cells into the dermal layer, resulting in red, scaly, and disfigured patches on the skin. The disease pathogenesis involves complex interactions among dendritic cells, T cells, and keratinocytes that activate TNF-a, IL-23/IL-17, and JAK/STAT pathways. Current therapies, such as topical corticosteroids, phototherapy, and biologics targeting specific cytokines, manifest considerable challenges, including adverse effects, treatment resistance, inconvenient administration, and prohibitive costs. Phosphodiesterase-4 (PDE4) inhibition represents a promising therapeutic strategy by preventing cAMP degradation and modulating inflammatory responses. Topical administration of a drug like Theobromine offers a significant advantage for psoriasis treatment, allowing targeted application to affected areas while minimizing systemic exposure and associated side effects. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9786209906527
Acheter neuf
EUR 83,12
Expédition à EUR 42,97
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis
Edité par
KS OmniScriptum Publishing, 2026
ISBN 10 : 6209906524
ISBN 13 : 9786209906527
Neuf
Taschenbuch
Vendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Role of PDE4 Inhibitor Through Theobromine Topical Cream in Psoriasis | Anand Vijayakumar Palur Ramkrishnan (u. a.) | Taschenbuch | Englisch | 2026 | KS OmniScriptum Publishing | EAN 9786209906527 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. N° de réf. du vendeur 135497679
Acheter neuf
EUR 57,20
Expédition à EUR 70
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 5 disponible(s)